Optimising antimicrobial therapy by understanding the interplay of host, pathogen, and drug

Aims and objectives

The ESCMID PK/PD of Anti-Infectives Study Group (EPASG) is dedicated to advancing the exploration and progression of pharmacodynamics and pharmacokinetics (PK/PD), as well as the dosing of anti-infectives. Its mission extends to innovative research on resistance development and paves the way for the development of ground-breaking antibiotics. As a European platform uniting scientists and healthcare providers actively engaged in these critical fields, EPASG is committed to: 

• Raising awareness on the critical role of exposure/effect relationships, advocating for optimal dosing strategies that ensure efficacy, safety, clinical outcomes, and resistance prevention
• Providing training and inspiration to scientists, physicians, and related groups through dynamic conferences, educational workshops, special symposia, and publications 
• Offering guidance and fostering knowledge among European countries, other ESCMID study groups, international societies, regulatory agencies, and government authorities